Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lord

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitorsMichael A Letavic, Emily M Stocking, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2007
Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitorsMichael A Letavic, John M Keith, Kiev S Ly, et al.
ACS Chemical Neuroscience|January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 AntagonistsJeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2007
Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2015
Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonistsMichael K Ameriks, Hong Ao, Nicholas I Carruthers, et al.
Frontiers in Pharmacology|June 27, 2017
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack ProvocationPascal Bonaventure, Christine Dugovic, Brock Shireman, et al.
ACS Chemical Neuroscience|January 12, 2016
Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat BrainChrista C Chrovian, Akinola Soyode-Johnson, Hong Ao, et al.
Neuropharmacology|January 19, 2016
P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsyHalima Amhaoul, Idrish Ali, Marco Mola, et al.
European Journal of Pharmacology|September 20, 2015
A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334Brian Lord, Michael K Ameriks, Qi Wang, et al.
European Journal of Medicinal Chemistry|June 16, 2009
Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylaminesCurt A Dvorak, Richard Apodaca, Wei Xiao, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitorsMichael A Letavic, Emily M Stocking, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2007
Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitorsMichael A Letavic, John M Keith, Kiev S Ly, et al.
ACS Chemical Neuroscience|January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 AntagonistsJeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2007
Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2015
Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonistsMichael K Ameriks, Hong Ao, Nicholas I Carruthers, et al.
Frontiers in Pharmacology|June 27, 2017
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack ProvocationPascal Bonaventure, Christine Dugovic, Brock Shireman, et al.
ACS Chemical Neuroscience|January 12, 2016
Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat BrainChrista C Chrovian, Akinola Soyode-Johnson, Hong Ao, et al.
Neuropharmacology|January 19, 2016
P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsyHalima Amhaoul, Idrish Ali, Marco Mola, et al.
European Journal of Pharmacology|September 20, 2015
A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334Brian Lord, Michael K Ameriks, Qi Wang, et al.
European Journal of Medicinal Chemistry|June 16, 2009
Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylaminesCurt A Dvorak, Richard Apodaca, Wei Xiao, et al.
Pageof 7